Endokrine Störungen và Đường tiêu hóa

Diez JJ, Molina I, Ibars MT (2003) Prevalence of thyroid dysfunction in adults over age 60 years from an urban community. Exp Clin Endocrinol Diabetes 111: 480–485 Volzke H, Ludemann J, Robinson DM et al (2003) The prevalence of undiagnosed thyroid disorders in a previously iodine-deficient area. Thyroid 13: 803–810 Boelaert K, Newby PR, Simmonds MJ et al (2010) Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease. Am J Med 123: 183–189 Hadithi M, BH de, Meijer JW et al (2007) Coeliac disease in Dutch patients with Hashimoto’s thyroiditis and vice versa. World J Gastroenterol 13: 1715–1722 Crowe JP, Christensen E, Butler J et al (1980) Primary biliary cirrhosis: the prevalence of hypothyroidism and its relationship to thyroid autoantibodies and sicca syndrome. Gastroenterology 78: 1437–1441 Checchi S, Montanaro A, Ciuoli C et al (2010) Prevalence of parietal cell antibodies in a large cohort of patients with autoimmune thyroiditis. Thyroid 20: 1385–1389 Lahner E, Centanni M, Agnello G et al (2008) Occurrence and risk factors for autoimmune thyroid disease in patients with atrophic body gastritis. Am J Med 121: 136–141 Dalton TA, Bennett JC (1992) Autoimmune disease and the major histocompatibility complex: therapeutic implications. Am J Med 92: 183–188 Hakanen M, Luotola K, Salmi J et al (2001) Clinical and subclinical autoimmune thyroid disease in adult celiac disease. Dig Dis Sci 46: 2631–2635 Leshin M (1985) Polyglandular autoimmune syndromes. Am J Med Sci 290: 77–88 Segni M, Borrelli O, Pucarelli I et al (2004) Early manifestations of gastric autoimmunity in patients with juvenile autoimmune thyroid diseases. J Clin Endocrinol Metab 89: 4944–4948 Ness-Abramof R, Nabriski DA, Braverman LE et al (2006) Prevalence and evaluation of B12 deficiency in patients with autoimmune thyroid disease. Am J Med Sci 332: 119–122 Hsing AW, Hansson LE, McLaughlin JK et al (1993) Pernicious anemia and subsequent cancer. A population-based cohort study. Cancer 71: 745–750 Kokkola A, Sjoblom SM, Haapiainen R et al (1998) The risk of gastric carcinoma and carcinoid tumours in patients with pernicious anaemia. A prospective follow-up study. Scand J Gastroenterol 33: 88–92 De Block CE, De Leeuw IH, Bogers JJ et al (2003) Autoimmune gastropathy in type 1 diabetic patients with parietal cell antibodies: histological and clinical findings. Diabetes care 26: 82–88 Eastwood GL, Braverman LE, White EM, Vander Salm TJ (1982) Reversal of lower esophageal sphincter hypotension and esophageal aperistalsis after treatment for hypothyroidism. J Clin Gastroenterol 4: 307–310 Lauritano EC, Bilotta AL, Gabrielli M et al (2007) Association between hypothyroidism and small intestinal bacterial overgrowth. J Clin Endocrinol Metab 92: 4180–4184 Seino Y, Matsukura S, Inoue Y et al (1978) Hypogastrinemia in hypothyroidism. Am J Dig Dis 23: 189–191 Yaylali O, Kirac S, Yilmaz M et al (2009) Does hypothyroidism affect gastrointestinal motility? Gastroenterol Res Pract 529802 Gunsar F, Yilmaz S, Bor S et al (2003) Effect of hypo- and hyperthyroidism on gastric myoelectrical activity. Dig Dis Sci 48: 706–712 Tobin MV, Fisken RA, Diggory RT et al (1989) Orocaecal transit time in health and in thyroid disease. Gut 30: 26–29 Shafer RB, Prentiss RA, Bond JH (1984) Gastrointestinal transit in thyroid disease. Gastroenterology 86: 852–855 Rahman Q, Haboubi NY, Hudson PR et al (1991) The effect of thyroxine on small intestinal motility in the elderly. Clin Endocrinol (Oxf) 35: 443–446 Abbasi AA, Douglass RC, Bissell GW, Chen Y (1975) Myxedema ileus. A form of intestinal pseudo-obstruction. JAMA 234: 181–183 Fred HL (1999) Curable conspicuous ascites: the forgotten four. Hosp Pract 34: 98–100 Melchert HU, Görsch B, Thierfelder W (2002) Schilddrüsenhormone und Schilddrüsenmedikamente bei Probanden in den Nationalen Gesundheitssurveys. In: Robert-Koch-Institut (Hrsg) Beiträge zur Gesundheitsberichterstattung des Bundes. rki, Berlin Jonderko K, Jonderko G, Marcisz C, Golab T (1997) Gastric emptying in hyperthyroidism. Am J Gastroenterol 92: 835–838 Bricker LA, Such F, Loehrke ME, Kavanaugh K (2001) Intractable diarrhea in hyperthyroidism: management with beta-adrenergic blockade. Endocr Pract 7: 28–31 Crane CW, Evans DW (1966) Thyrotoxic steatorrhoea. Br Med J 2: 1575 Thomas FB, Caldwell JH, Greenberger NJ (1973) Steatorrhea in thyrotoxicosis. Relation to hypermotility and excessive dietary fat. Ann Intern Med 78: 669–675 Varsamidakis N, Kanakis M, Thomas T et al (2009) Dysphagia as the presenting symptom of thyroid cancer. Exp Clin Endocrinol Diabetes 117: 511–513 Camiel MR, Mule JE, Alexander LL, Benninghoff DL (1968) Association of thyroid carcinoma with Gardner’s syndrome in siblings. N Engl J Med 278: 1056–1058 Linde K van der, Vasen HF, Vliet AC van (1998) Occurrence of thyroid carcinoma in Dutch patients with familial adenomatous polyposis. An epidemiological study and report of new cases. Eur J Gastroenterol Hepatol 10: 777–781 Plail RO, Bussey HJ, Glazer G, Thomson JP (1987) Adenomatous polyposis: an association with carcinoma of the thyroid. Br J Surg 74: 377–380 Perrier ND, Heerden JA van, Goellner JR et al (1998) Thyroid cancer in patients with familial adenomatous polyposis. World J Surg 22: 738–742 Kebebew E, Ituarte PH, Siperstein AE et al (2000) Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems. Cancer 88: 1139–1148 Heubi JE, Partin JC, Schubert WK (1983) Hypocalcemia and steatorrhea – clues to etiology. Dig Dis Sci 28: 124–128 Ebert EC (2010) The parathyroids and the gut. J Clin Gastroenterol 44: 479–482 Greenberger NJ, Ockenga J (2005) Akute und chronische Pankreatitis. In: Harrisons Innere Medizin, 16. Aufl. McGraw-Hill, Frankfurt, S 2040–2051 Carnaille B, Oudar C, Pattou F et al (1998) Pancreatitis and primary hyperparathyroidism: forty cases. Aust NZJ Surg 68: 117–119 Felderbauer P, Karakas E, Fendrich V et al (2011) Multifactorial genesis of pancreatitis in primary hyperparathyroidism: evidence for „protective“ (PRSS2) and „destructive“ (CTRC) genetic factors. Exp Clin Endocrinol Diabetes 119: 26–29 Felderbauer P, Karakas E, Fendrich V et al (2008) Pancreatitis risk in primary hyperparathyroidism: relation to mutations in the SPINK1 trypsin inhibitor (N34S) and the cystic fibrosis gene. Am J Gastroenterol 103: 368–374 Cannon J, Lew JI, Solorzano CC (2010) Parathyroidectomy for hypercalcemic crisis: 40 years‘ experience and long-term outcomes. Surgery 148: 807–812 Kelly TR, Falor WH (1968) Hyperparathyroid crisis associated with pancreatitis. Ann Surg 168: 917–920 Celik I, Apras S, Kars A et al (1998) Persistent hypercalcemia leading to acute pancreatitis in a patient with relapsed myeloma and renal failure. Nephron 79: 109–110 Ono Y, Kimura T, Nakano I et al (1996) Acute pancreatitis induced by hypercalcaemia associated with adult T-cell leukaemia: a case report. J Gastroenterol Hepatol 11: 193–195 Sakorafas GH, Tsiotou AG (2000) Etiology and pathogenesis of acute pancreatitis: current concepts. J Clin Gastroenterol 30: 343–356 Thrower EC, Gorelick FS, Husain SZ (2010) Molecular and cellular mechanisms of pancreatic injury. Curr Opin Gastroenterol 26: 484–489 Burgess J (2010) How should the patient with multiple endocrine neoplasia type 1 (MEN 1) be followed? Clin Endocrinol (Oxf) 72: 13–16 Ballard HS, Fame B, Hartsock RJ (1964) Familial multiple endocrine adenoma-peptic ulcer complex. Medicine (Baltimore) 43: 481–516 Hoffmann KM, Gibril F, Entsuah LK et al (2006) Patients with multiple endocrine neoplasia type 1 with gastrinomas have an increased risk of severe esophageal disease including stricture and the premalignant condition, Barrett’s esophagus. J Clin Endocrinol Metab 91: 204–212 Proye CA, Lokey JS (2004) Current concepts in functioning endocrine tumors of the pancreas. World J Surg 28: 1231–1238 Dejong CH, Parks RW, Currie E et al (2002) Treatment of hepatic metastases of neuroendocrine malignancies: a 10-year experience. J R Coll Surg Edinb 47: 495–499 Edery P, Lyonnet S, Mulligan LM et al (1994) Mutations of the RET proto-oncogene in Hirschsprung’s disease. Nature 367: 378–380 Romeo G, Ceccherini I, Celli J et al (1998) Association of multiple endocrine neoplasia type 2 and Hirschsprung disease. J Intern Med 243: 515–520 Cohen MS, Phay JE, Albinson C et al (2002) Gastrointestinal manifestations of multiple endocrine neoplasia type 2. Ann Surg 235: 648–654